152 related articles for article (PubMed ID: 6782875)
1. Sulfonylureas and platelet function.
Klaff LJ; Kernoff L; Vinik AI; Jackson WP; Jacobs P
Am J Med; 1981 Mar; 70(3):627-30. PubMed ID: 6782875
[TBL] [Abstract][Full Text] [Related]
2. Lack of effect of gliclazide on platelet aggregation in insulin-treated and non-insulin-treated diabetes: a two-year controlled study.
Larkins RG; Jerums G; Taft JL; Godfrey H; Smith IL; Martin TJ
Diabetes Res Clin Pract; 1988 Jan; 4(2):81-7. PubMed ID: 3125029
[TBL] [Abstract][Full Text] [Related]
3. Anti-platelet effects of long-term treatment with gliclazide in diabetic patients.
Ponari O; Civardi E; Megha S; Pini M; Portioli D; Dettori AG
Thromb Res; 1979; 16(1-2):191-203. PubMed ID: 116387
[No Abstract] [Full Text] [Related]
4. Effects of the sulphonylurea drugs gliclazide and glibenclamide on blood glucose control and platelet function.
Klaff LJ; Vinik AI; Jackson WP; Malan E; Kernoff L; Jacobs P
S Afr Med J; 1979 Aug; 56(7):247-50. PubMed ID: 121645
[TBL] [Abstract][Full Text] [Related]
5. Comparison of gliclazide and glibenclamide treatment in non-insulin-dependent diabetes.
Baba S; Nakagawa S; Takebe K; Goto Y; Maezawa H; Takeda R; Sakamoto N; Fukui I
Tohoku J Exp Med; 1983 Dec; 141 Suppl():693-706. PubMed ID: 6440313
[TBL] [Abstract][Full Text] [Related]
6. The effects of gliclazide on platelet function in patients with diabetes mellitus.
Violi F; De Mattia GC; Alessandri C; Perrone A; Vezza E
Curr Med Res Opin; 1982; 8(3):200-3. PubMed ID: 7128193
[TBL] [Abstract][Full Text] [Related]
7. Effect of glycaemic control, metformin and gliclazide on platelet density and aggregability in recently diagnosed type 2 (non-insulin-dependent) diabetic patients.
Collier A; Watson HH; Patrick AW; Ludlam CA; Clarke BF
Diabete Metab; 1989; 15(6):420-5. PubMed ID: 2534084
[TBL] [Abstract][Full Text] [Related]
8. [Effects of gliclazide and glibenclamide on platelet function, fibrinolysis and metabolic control in diabetic patients with retinopathy (author's transl)].
Chan TK; Chan V; Teng CS; Yeung RT
Sem Hop; 1982 May; 58(19):1197-200. PubMed ID: 6285503
[TBL] [Abstract][Full Text] [Related]
9. Free radical scavenging activity of sulfonylureas: a clinical assessment of the effect of gliclazide.
Jennings PE; Belch JJ
Metabolism; 2000 Feb; 49(2 Suppl 1):23-6. PubMed ID: 10693916
[TBL] [Abstract][Full Text] [Related]
10. Increased platelet aggregation in early diabetus mellitus.
Sagel J; Colwell JA; Crook L; Laimins M
Ann Intern Med; 1975 Jun; 82(6):733-8. PubMed ID: 1138583
[TBL] [Abstract][Full Text] [Related]
11. Altered platelet function in diabetes mellitus.
Colwell JA; Halushka PV; Sarji K; Levine J; Sagel J; Nair RM
Diabetes; 1976; 25(2 SUPPL):826-31. PubMed ID: 823064
[TBL] [Abstract][Full Text] [Related]
12. [Effect of gliclazide on platelet behavior].
Verry M; Dechavanne M; Desnoyers P; Stoltz JF; Vainer H
Nouv Presse Med; 1974 Oct; 3(33):2099-100. PubMed ID: 4471584
[No Abstract] [Full Text] [Related]
13. Increased synthesis of prostaglandin-E-like material by platelets from patients with diabetes mellitus.
Halushka PV; Lurie D; Colwell JA
N Engl J Med; 1977 Dec; 297(24):1306-10. PubMed ID: 917087
[TBL] [Abstract][Full Text] [Related]
14. Removal of extraplatelet Na+ eliminates indomethacin-sensitive secretion from human platelets stimulated by epinephrine, ADP, and thrombin.
Connolly TM; Limbird LE
Proc Natl Acad Sci U S A; 1983 Sep; 80(17):5320-4. PubMed ID: 6577431
[TBL] [Abstract][Full Text] [Related]
15. [Macroangiopathy and type 2 diabetes mellitus: significance of Diamicron].
Lesobre B
Journ Annu Diabetol Hotel Dieu; 1990; ():325-34. PubMed ID: 2195215
[No Abstract] [Full Text] [Related]
16. Inhibition of labile aggregation-stimulating substance (LASS) and platelet aggregation in diabetes mellitus.
Colwell JA; Chambers A; Laimins M
Diabetes; 1975 Jul; 24(7):684-7. PubMed ID: 1158034
[TBL] [Abstract][Full Text] [Related]
17. Platelet monoamine oxidase and epinephrine-induced platelet aggregation.
Rossi EC; Louis G; Bieber M; Zeller EA
Thromb Haemost; 1978 Aug; 40(1):37-42. PubMed ID: 725849
[TBL] [Abstract][Full Text] [Related]
18. Platelet behaviour in non-insulin-dependent diabetes--influence of vascular complications, treatment and metabolic control.
Peacock I; Hawkins M; Heptinstall S
Thromb Haemost; 1986 Jun; 55(3):361-5. PubMed ID: 3092392
[TBL] [Abstract][Full Text] [Related]
19. Gliclazide. A preliminary review of its pharmacodynamic properties and therapeutic efficacy in diabetes mellitus.
Holmes B; Heel RC; Brogden RN; Speight TM; Avery GS
Drugs; 1984 Apr; 27(4):301-27. PubMed ID: 6373223
[TBL] [Abstract][Full Text] [Related]
20. [Platelet aggregation induced by adenosine diphosphate, collagen and adrenaline in human platelet subpopulations].
Nubile G; Di Gregorio M; Ridolfi D; D'Alonzo L; Izzi L
Quad Sclavo Diagn; 1987 Sep; 23(3):331-40. PubMed ID: 3140287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
